ANVISA: 90% CI for AUCINF in 72hrs truncated BE Study [Regulatives / Guidelines]

posted by Nirali  – India, 2007-09-21 08:26 (6434 d 23:14 ago) – Posting: # 1104
Views: 6,371

Dear Group Members,

Is calculation of 90%CI required for AUCINF while doing ANVISA submission for 72hrs truncated single dose, crossover BE study?

Product has long half life-70hrs. Therefore planned to truncate AUC upto 72hrs. ANVISA guideline has not clearly mentioned that 90%CI for AUCINF is required or not, for the same.

Would you pls explain the importance of AUCINF in 72hrs-truncated BE study?


Thanks & Regards,
Nirali

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
66 visitors (0 registered, 66 guests [including 8 identified bots]).
Forum time: 07:41 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5